# Multi-center Trial of Ferric Derisomaltose in Children 0 to <18 Years of Age With Iron Deficiency Anemia

> **NCT05179226** · PHASE3 · RECRUITING · sponsor: **Pharmacosmos A/S** · enrollment: 200 (estimated)

## Conditions studied

- Iron Deficiency, Anaemia in Children

## Interventions

- **DRUG:** Ferric Derisomaltose

## Key facts

- **NCT ID:** NCT05179226
- **Lead sponsor:** Pharmacosmos A/S
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2022-11-28
- **Primary completion:** 2026-04-30
- **Final completion:** 2026-04-30
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2026-04-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05179226

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05179226, "Multi-center Trial of Ferric Derisomaltose in Children 0 to <18 Years of Age With Iron Deficiency Anemia". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05179226. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*